MARC details
000 -LEADER |
fixed length control field |
01960nam a22002417a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
ISI Library, Kolkata |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240806151230.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
240806b |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9241207604 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
ISI Library |
Language of cataloging |
English |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
100 SD;610.621 |
Item number |
WHO.TR.760 |
110 1# - MAIN ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
WHO Expert Committee on Biological Standardization |
245 10 - TITLE STATEMENT |
Title |
WHO Expert Committee on Biological Standardization : |
Remainder of title |
thirty-seventh report, meeting held in Geneva from 1 to 8 December 1986 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Geneva : |
Name of publisher, distributor, etc |
World Health Organization, |
Date of publication, distribution, etc |
1987 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
203 Pages; |
Dimensions |
20 cm. |
490 0# - SERIES STATEMENT |
Series statement |
World Health Organization technical report series ; no. 760 |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
General -- Substances: Antibiotics -- Antibodies -- Blood products and related substances -- Endocrinological and related substances -- Miscellaneous -- requirements for biological substances -- Annaxes |
520 ## - SUMMARY, ETC. |
Summary, etc |
Announces changes in the status or development of international standards for 35 biologicals, classified as antibiotics, antibodies, antigens, blood products and related substances, endocrinological and related substances, and a miscellaneous group of substances. The report also provides detailed information on requirements for the manufacturing, testing, and quality control of selected vaccines, including hepatitis B vaccines made by recombinant DNA techniques in yeast, live mumps vaccine, and inactivated rabies vaccine produced in continuous cell lines. Of particular practical interest is an extensive report on a WHO meeting concerned with the use of recombinant DNA techniques to produce hepatitis B vaccines. The report also includes amendments to previous requirements for oral poliomyelitis vaccine and for diphtheria toxoid, pertussis vaccine, tetanus toxoid, and combined vaccines. |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Biological Products |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmacology, Toxicology and Clinical Technology |
710 1# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
World Health Organization |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Reports |